DK258989D0 - Anvendelse af et xanthinderivat til inhibering af tnf og middel hertil - Google Patents

Anvendelse af et xanthinderivat til inhibering af tnf og middel hertil

Info

Publication number
DK258989D0
DK258989D0 DK258989A DK258989A DK258989D0 DK 258989 D0 DK258989 D0 DK 258989D0 DK 258989 A DK258989 A DK 258989A DK 258989 A DK258989 A DK 258989A DK 258989 D0 DK258989 D0 DK 258989D0
Authority
DK
Denmark
Prior art keywords
agents
inhibit tnf
derivative
xanthin
tnf
Prior art date
Application number
DK258989A
Other languages
English (en)
Other versions
DK258989A (da
Inventor
Heinz Haenel
Elmar Schrinner
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK258989D0 publication Critical patent/DK258989D0/da
Publication of DK258989A publication Critical patent/DK258989A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK258989A 1988-05-27 1989-05-26 Anvendelse af et xanthinderivat til inhibering af tnf og middel hertil DK258989A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3817955A DE3817955A1 (de) 1988-05-27 1988-05-27 Tnf-inhibitor enthaltendes arzneimittel

Publications (2)

Publication Number Publication Date
DK258989D0 true DK258989D0 (da) 1989-05-26
DK258989A DK258989A (da) 1989-11-28

Family

ID=6355195

Family Applications (1)

Application Number Title Priority Date Filing Date
DK258989A DK258989A (da) 1988-05-27 1989-05-26 Anvendelse af et xanthinderivat til inhibering af tnf og middel hertil

Country Status (9)

Country Link
US (1) US5118500A (da)
EP (1) EP0344586B1 (da)
JP (1) JP3140021B2 (da)
AT (1) ATE135225T1 (da)
DE (2) DE3817955A1 (da)
DK (1) DK258989A (da)
ES (1) ES2086309T3 (da)
GR (1) GR3020101T3 (da)
PT (1) PT90660B (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672347A (en) * 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
US5272153A (en) * 1986-12-31 1993-12-21 Hoechst-Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5196429A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5196430A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US6541610B1 (en) 1989-09-05 2003-04-01 Immunex Corporation Fusion proteins comprising tumor necrosis factor receptor
DE59010933D1 (de) 1989-09-12 2003-05-08 Hoffmann La Roche TFN-bindende Proteine
DE4019571A1 (de) * 1990-06-20 1992-01-02 Hoechst Ag Pharmazeutische kombinationspraeparate enthaltend cephalosporin- und xanthinderivate und deren verwendung
US5958413A (en) * 1990-11-01 1999-09-28 Celltech Limited Use of antibodies to TNF or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor
WO1992007566A2 (en) * 1990-11-01 1992-05-14 Board Of Regents, The University Of Texas System Antifungal activity of and prevention of drug induced nephrotoxicity by methylxanthine analogues
NZ240644A (en) * 1990-11-21 1994-08-26 Smithkline Beecham Corp Use of xanthine derivatives to inhibit the production of tumour necrosis factor (tnf)
IL100194A0 (en) * 1990-11-30 1992-08-18 Hoechst Roussel Pharma Use of xanthines for the preparation of a medicament effective for inhibiting the effects of allograft reaction in humans
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
US5856115A (en) * 1991-05-24 1999-01-05 Fred Hutchinson Cancer Research Center Assay for identification therapeutic agents
US5795859A (en) * 1991-07-05 1998-08-18 Peptide Technology Limited Peptide which abrogates TNF and/or LPS toxicity
ES2038546B1 (es) * 1991-11-08 1994-02-16 Andromaco Lab Procedimiento de obtencion de un producto de naturaleza polipeptidica con actividad inhibidora de la hiperproduccion del factor de necrosis tumoral.
US5580874A (en) * 1992-03-04 1996-12-03 Cell Therapeutics, Inc. Enatiomerically pure hydroxylated xanthine compounds
US5648357A (en) * 1992-03-04 1997-07-15 Cell Therapeutics, Inc. Enatiomerically pure hydroxylated xanthine compounds
ES2191013T3 (es) * 1992-03-04 2003-09-01 Cell Therapeutics Inc Compuestos de xantina enantiomeros hidroxilados.
AU671116B2 (en) * 1992-03-30 1996-08-15 Immunex Corporation Fusion proteins comprising tumor necrosis factor receptor
PL173978B1 (pl) * 1992-07-13 1998-05-29 Nika Health Products Ltd Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej
US6183742B1 (en) 1992-07-13 2001-02-06 Nika Health Products, Limited Applications of lysozyme dimer
US5817662A (en) * 1992-11-09 1998-10-06 Cell Therapeutics, Inc. Substituted amino alkyl compounds
US6693105B1 (en) 1992-11-16 2004-02-17 Cell Therapeutics, Inc. Hydroxyl-containing compounds
US5804584A (en) * 1992-11-16 1998-09-08 Cell Therapeutics, Inc. Therapeutic compounds containing a monocyclic five- to six- membered ring structure having one to two nitrogen atoms
US5795897A (en) * 1992-11-18 1998-08-18 Cell Therapeutics, Inc. Oxohexyl methylxanthine compounds
AU6087894A (en) * 1993-01-14 1994-08-15 Cell Therapeutics, Inc. Acetal or ketal substituted therapeutic compounds
AU6092794A (en) * 1993-01-19 1994-08-15 Cell Therapeutics, Inc. Oxime-substituted therapeutic compounds
EP0728003A1 (en) * 1993-11-12 1996-08-28 Cell Therapeutics, Inc. Method for preventing tissue injury from hypoxia
US6103730A (en) * 1994-03-24 2000-08-15 Cell Therapeutics, Inc. Amine substituted compounds
EP0746557A4 (en) * 1994-02-18 1997-05-02 Cell Therapeutics Inc INTRACELLULAR SIGNALING MEDIATORS
US5807861A (en) * 1994-03-24 1998-09-15 Cell Therapeutics, Inc. Amine substituted xanthinyl compounds
US5801182A (en) * 1994-03-24 1998-09-01 Cell Therapeutics, Inc. Amine substituted compounds
US6010711A (en) * 1996-01-26 2000-01-04 University Of Rochester Methods, articles and compositions for the pharmacologic inhibition of bone resorption with phosphodiesterase inhibitors
DE19707655A1 (de) * 1997-02-26 1998-08-27 Hoechst Ag Kombinationspräparat zur Anwendung bei Demenz
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
US20030207901A1 (en) * 1999-07-27 2003-11-06 Cell Therapeutics, Inc. Hydroxyl-containing compounds
WO2001087328A2 (en) 2000-05-12 2001-11-22 Immunex Corporation Interleukin-1 inhibitors in the treatment of diseases
US7101978B2 (en) * 2003-01-08 2006-09-05 Applied Molecular Evolution TNF-α binding molecules
US7892563B2 (en) 2003-05-20 2011-02-22 Wyeth Holdings Corporation Methods for treatment of severe acute respiratory syndrome (SARS)
US7435799B2 (en) * 2004-01-08 2008-10-14 Applied Molecular Evolution TNF-α binding molecules
CA2560889A1 (en) * 2004-03-23 2005-10-13 Sanjay D. Khare Monoclonal antibodies specific for human ox40l (cd 134l)
SG11202105238YA (en) 2018-11-19 2021-06-29 Univ Texas Suicide gene

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879111A (en) * 1986-04-17 1989-11-07 Cetus Corporation Treatment of infections with lymphokines

Also Published As

Publication number Publication date
ATE135225T1 (de) 1996-03-15
EP0344586B1 (de) 1996-03-13
DE3817955A1 (de) 1989-11-30
DE58909621D1 (de) 1996-04-18
JPH0219327A (ja) 1990-01-23
GR3020101T3 (en) 1996-08-31
US5118500A (en) 1992-06-02
ES2086309T3 (es) 1996-07-01
EP0344586A2 (de) 1989-12-06
PT90660A (pt) 1989-11-30
EP0344586A3 (en) 1990-05-16
DK258989A (da) 1989-11-28
PT90660B (pt) 1994-10-31
JP3140021B2 (ja) 2001-03-05

Similar Documents

Publication Publication Date Title
DK258989D0 (da) Anvendelse af et xanthinderivat til inhibering af tnf og middel hertil
DK162472C (da) Laegemiddelform til afgivelse af et terapeutisk middel i periodontallommen og dens omgivelser
DE3873879D1 (de) Nicht-sedative antihistaminica enthaltende husten-/schnupfenmittel.
DK72284D0 (da) Farmaceutisk middel med metabolisk og energetisk virkning til anvendelse i kardial- og vaskulaerterapi
DK543189A (da) Lysyloxidaseinhibitorer og deres anvendelse
ZA882884B (en) Cough/cold mixtures comprising non-sedating antihistamine drugs
DK648487A (da) Spiro-substituerede glutaramid-derivater og deres medicinske anvendelse samt farmaceutiske praeparater indeholdende disse forbindelser
DK99790D0 (da) Indretning til opbevaring, blanding og afgivelse af to forskellige fluida
DK462486A (da) Farmaceutisk tablet indeholdende cefuroxim-axetil
DK290188A (da) Alkoxysubstituerede dihydrobenzopyran-2-carboxylatderivater og farmaceutiske acceptable salte deraf samt deres anvendelse
DK108888A (da) Farmaceutisk tablet, farmaceutisk granulat og fremgangsmaader til fremstilling af henholdsvis denne tablet og dette granulat
DK453684D0 (da) Pyridinderivater til medicinsk anvendelse og farmaceutiske praeparater indeholdende pyridinderivater
DK453584A (da) Pyridinderivater til medicinsk anvendelse og farmaceutiske praeparater indeholdende pyridinderivater
DE3685170D1 (de) Histaminderivate enthaltende pharmazeutische zusammensetzung.
DK273689D0 (da) 4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler
DK610284A (da) 2-phenyl-imidazolderivater, deres fremstilling og laegemidler indeholdende disse forbindelser
DK40487D0 (da) Heterocycliske lipoxygenaseinhibitorer og farmaceutisk acceptable salte deraf
DK663189A (da) 7-oxabicycloheptyl-substituerede heterocycliske amid-prostaglandin-analoge og deres anvendelse i laegemidler
DK163990C (da) Oxindol-3-carboxamid-derivater og farmaceutiske praeparater indeholdende disse
DK165985C (da) 1-cytosinderivater, fremgangsmaader til deres fremstilling, samt anvendelse af dem i og til fremstilling af laegemidler
DK175287D0 (da) Esterprolaegemidler af dopamin-beta-hydroxy-lase-inhibitorer og fremgangsmaade til fremstillings deraf samt farmaceutisk middel indeholdende disse
DK0563060T3 (da) Anvendelse af IL-4 og TNF til fremstilling af et lægemiddel til behandling af tumorceller
DK628086D0 (da) Pyrazinderivater og farmaceutisk acceptable salte heraf samt fremgangsmaade til fremstilling af og farmaceutisk komposition indeholdende samme
DK162092C (da) Basisk substituerede 3-phenyl-quinolin-2-on-derivater, deres fremstilling og anvendelse samt laegemiddel indeholdende disse derivater
DK488688D0 (da) Azolidindion-derivater og farmaceutiske praeparater indeholdende disse

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment